ROLE OF BETA LACTAMASES IN ANTIBIOTIC RESISTANCE: A REVIEW
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2014, Vol 5, Issue 2
Abstract
Penicillin, the first β-lactam antibiotic was introduced into clinical practice in 1940s. Since then a large number of different β-lactam antibiotics including penicillins, cephalosporins, monobactam and carbapenems have been developed. All of them are structurally related through the presence of a core β-lactam ring. β-lactam antibiotics interfere with the synthesis of bacterial cell wall, they also inhibit the transpeptidases so that cross linking does not take place. The wide use of β-lactam antibiotics has created major resistance problems leading to increased morbidity, mortality and heath care costs. Resistance is most often mediated by lactamases which is produced from both gram negative and positive bacteria. β-lactamases are enzymes responsible for many failures of antimicrobial therapy because of the hydrolysis of β-lactam antibiotics to inert and ineffective agents. β-lactamases are one of the reason behind the bacterial resistance to β- lactam antibiotics. In recent years new varieties of beta lactamases has been detected in increasing rate. Combination of β-lactam antibiotics with β-lactamases inhibitors has been successfully used to control resistance during last two decades. These inhibitors greatly enhance the efficacy of their partner β-lactam antibiotics (amoxillin, ampicillin, piperacillin, and ticarcillin) in the treatment of serious Entero bacteriaceae and penicillin resistant Staphylococcal infections. The prevalence of clinically relevant β-lactamases from other classes that are resistant to inhibition is rapidly increasing. Lack of effectiveness of currently available β-lactamase inhibitors is a main problem with the combination therapy. This review describes the various β-lactum antibiotics and effect of different β –lactamases that produced by the several bacteria’s against the β-lactam antibiotics, their resistance pattern and its effective management with combination therapy.
Authors and Affiliations
R. Lakshmi, K. S Nusrin, Georgy Ann
RP-HPLC METHOD DEVELOPMENT FOR THE SUBSTITUTED BENZENE DERIVATIVE OF EUGENOL
A simple Reverse phase liquid chromatographic method has been developed and subsequently validated for the derivative of the Phenyl substituted derivatives on the hydroxyl proton of Eugenol. The separation was carried ou...
EVALUATION OF HYPOGLYCEMIC AND WOUND HEALING ACTIVITIES OF LANTANA WIGHTIANA WALL. EX GAMBLE LEAVES
Lantana wightiana Wall, a member of Verbenaceae is an unarmed sub shrub, up to 3 m tall. The present study was aimed at evaluating the hypoglycemic and wound healing activities of Lantana wightiana. The leaves were colle...
XIMELAGATRAN: A NEW DIRECT THROMBIN INHIBITOR
Venous thromboembolism is a serious illness that affects patient morbidity and mortality and presents a significant management challenge to healthcare providers world-wide. Despite major achievements in the significant r...
SPECTROPHOTOMETRIC METHODS FOR SIMULTANEOUS ESTIMATION OF ATORVASTATIN AND NIACIN IN TABLET DOSAGE FORM
Two UV spectrophotometric methods were developed and validated for quantitative determination of atorvastatin (ATR) and niacin (NIA) in tablet dosage form. Method I is based on the simultaneous equation, and method II is...
GREEN APPROACH FOR THE SYNTHESIS OF ZINC NANOPARTICLES AND ITS ANTIBACTERIAL ACTIVITY
Green nanotechnology is an eco-friendly approach for the synthesis of metal nanoparticles and a promising alternative for chemical methods. In this study, we have synthesized zinc nanoparticles by utilizing the leaf extr...